Artificial Intelligence

How Agentic AI and Digital Twins Aim to Reshape Food Formulation Amid Rising GLP-1 Use

· GlobeWire Daily Editorial Desk · Source: www.prnewswire.com

2 min read

Key takeawaysA reported rise in the adoption of GLP-1 medications across United States households is prompting discussions about new formulation challenges for the food industry, according to a recent announcement from PIPA.
How Agentic AI and Digital Twins Aim to Reshape Food Formulation Amid Rising GLP-1 Use

Original GlobeWire Daily editorial illustration — not an event photograph.

A reported rise in the adoption of GLP-1 medications across United States households is prompting discussions about new formulation challenges for the food industry, according to a recent announcement from PIPA.

Data cited from PwC indicates that 21% of U.S. households included a current GLP-1 user in May 2026, compared to 9% in January 2025. Additionally, Circana reported that 65% of these users seek increased protein, while BCG noted that 70% of users observed changes in eating or fitness habits within their households.

The Technical Challenge of Food Reformulation

Modifying food products to include higher levels of protein or fiber often presents complex trade-offs for manufacturers. According to industry insights:

  • Nutritional Targets: Adding nutrients can alter product structure and texture.
  • Processing Stability: Ingredients must remain stable during manufacturing.
  • Cost Constraints: Trial-and-error development can become expensive when balancing these factors.

The Role of FIOS and Digital Twins

To address these hurdles, PIPA highlights its Food Innovation Operating System (FIOS®), which combines artificial intelligence with physics-based digital twins.

  • Agentic Workflows: Designed to screen various ingredient combinations against nutritional, functional, and commercial goals.
  • Process Modeling: Anticipates manufacturing line outcomes before physical trials take place.
  • Reported Efficiency: Users reportedly see up to 40% performance gains when formulation optimization is linked with downstream process parameters.

"GLP-1 is changing the brief for everyday foods," stated Eric Hamborg, Chief Commercial Officer of PIPA, emphasizing that manufacturers require tools to navigate trade-offs early in the development stage.

Practical Implications and Verification

Companies looking to adapt to changing consumer demands can evaluate technology platforms through authorized channels. PIPA offers a trial option for FIOS on its official website at pipacorp.com. Stakeholders should review primary data sources, such as reports from PwC, Circana, and BCG, to verify consumer adoption statistics independently.

Share this article
Read the original source: The GLP-1 Effect: How Agentic AI and Digital Twins with FIOS® Can Redesign America's Food

AI-assisted reporting; source claims are attributed and have not been independently verified.

About the author

GlobeWire Daily Editorial Desk — AI-assisted news based on attributed published sources.

More to read